Form 4: Praxis Precision Medicines CEO Sells Shares to Cover Tax Obligations

Praxis Precision Medicines CEO, Marcio Souza, sold 434 shares of common stock to cover tax obligations related to vesting restricted share units.

Summary

• Marcio Souza, the CEO of Praxis Precision Medicines, sold 434 shares of common stock on January 7, 2025.
• The sale was executed at a price of $77.52 per share.
• This transaction was to cover tax withholding obligations related to the vesting of previously reported restricted share units.
• Following the transaction, Mr. Souza directly owns 16,460 shares of common stock.
• Mr. Souza also indirectly owns 3,000 shares held by his spouse.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of executive compensation packages, leading to similar tax-related sales.
• The sale of 434 shares is relatively small compared to the total holdings of the CEO, which is typical for tax-related transactions.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Praxis Precision Medicines, Marcio Souza, stock sale, insider trading, tax obligations, restricted share units, executive compensation